RISPERDAL CONSTA FOR INJECTION 37.5 mg/vial
Product details
Registration number: SIN12354P
Classification: Prescription Only
Active ingredients: RISPERIDONE
Strength: 37.5 mg/vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAMUSCULAR
Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD
ATC code: N05AX08
HSA approval date: 21 July 2003
Manufacturer(s):
- Cilag AG
- ALKERMES INCORPORATED
Manufacturing country/countries: UNITED STATES; SWITZERLAND
What are the HSA registration number and classification for RISPERDAL CONSTA FOR INJECTION 37.5 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN12354P
Classification: Prescription Only
What active ingredients and strength are recorded for RISPERDAL CONSTA FOR INJECTION 37.5 mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: RISPERIDONE
Strength: 37.5 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for RISPERDAL CONSTA FOR INJECTION 37.5 mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAMUSCULAR
Who is the recorded registrant for RISPERDAL CONSTA FOR INJECTION 37.5 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for RISPERDAL CONSTA FOR INJECTION 37.5 mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Cilag AG
- ALKERMES INCORPORATED
Manufacturing country/countries: UNITED STATES; SWITZERLAND
Where can I look up RISPERDAL CONSTA FOR INJECTION 37.5 mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN12354P or the exact product name RISPERDAL CONSTA FOR INJECTION 37.5 mg/vial. The general register link does not preselect this product.
What are the source dates for this RISPERDAL CONSTA FOR INJECTION 37.5 mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this RISPERDAL CONSTA FOR INJECTION 37.5 mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN12354P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)